[Combination of anticholinergic, beta-2-sympathomimetic agents and theophylline in the treatment of chronic obstructive lung disease. A double-blind multicenter study of 60 patients].
D000328:Adult; D000368:Aged; D001286:Atropine Derivatives / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005260:Female; D005280:Fenoterol / Q000627:therapeutic use*; D006801:Humans; D009241:Ipratropium / Q000627:therapeutic use*; D008173:Lung Diseases, Obstructive / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011897:Random Allocation; D013806:Theophylline / Q000627:therapeutic use*
D001286:Atropine Derivatives; D005280:Fenoterol; D013806:Theophylline; D009241:Ipratropium
Die Kombination von Anticholinergika, Beta-2-Sympathomimetika und Theophyllin in der Behandlung der chronischen obstruktiven Lungenkrankheit. Eine doppelblinde randomisierte Multicenterstudie mit 60 Patienten.